Titlebook: Maternal Drug Use and Infant Congenital Malformations; Bengt K?llén Book 2019 Springer Nature Switzerland AG 2019 birth defects.teratogeni

自戀

清楚說話

起來了

Background,of ascertainment of congenital malformations and of drug exposure are described, the problem of confounding and of mass significance. A detailed description of the system used when analyzing the Swedish health registers with its positive and negative aspects is given.

obsolete

幾何學(xué)家

褲子

Urea508

斷言

Maternal Use of Anticoagulants or Hemostatic Drugs and Infant Congenital Malformations,l use of either anticoagulants or hemostatic drugs and a relatively severe malformation, notably a cardiovascular defect, in the offspring. This association is probably the result of a confounding by indication: a coagulopathy or a bleeding disorder.

歌劇等

Maternal Use of Drugs for Cardiovascular Diseases and Infant Congenital Malformations,arly pregnancy. There seems to be no certain difference between drugs with different mechanisms of action in this association and an increased risk is also seen in infants of women with a diagnosis of hypertension but without any reported use of anti-hypertensive drugs. It seems likely that the effe

Nefarious

Maternal Use of Dermatologic Drugs and Infant Congenital Malformations,nlikely which is supported by new data for some of the most commonly used such drugs, e.g., topical corticosteroids. Topically used retinoids (e.g., tretinoin) should be avoided during pregnancy but presently available data do not suggest a marked teratogenic risk. Systemic use of retinoids (notably